Clinical Trial

Risk Factors for Non-response to Hormonal Medical Therapy in Patients With Endometriosis

Recruiting
View on ClinicalTrials.gov →
Summary
Determine the proportion of patients with endometriosis unresponsive to medical therapy and to compare the clinical and ultrasonographic characteristics of this group of patients (study group) with the clinical and ultrasonographic characteristics of patients responsive to medical therapy (control group).
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-05-09.
Trial Details
NCT Number NCT06413381
Lead Sponsor IRCCS Azienda Ospedaliero-Universitaria di Bologna
Conditions Endometriosis
Enrollment 250 participants
Start Date 2024-04-19
Primary Completion 2028-08-31 (estimated)
Study Completion 2029-11-28 (estimated)
Updated on ClinicalTrials.gov 2024-08-01